Filing Details
- Accession Number:
- 0001415889-24-028018
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-02 19:07:34
- Reporting Period:
- 2024-12-02
- Accepted Time:
- 2024-12-02 19:07:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1211583 | Fennec Pharmaceuticals Inc. | FENC | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1185945 | A Chris Rallis | C/O Fennec Pharmaceuticals, Inc. Po Box 13628, 68 Tw Alexander Drive Research Triangle Park NC 27709 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2024-12-02 | 10,000 | $2.69 | 58,623 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2024-12-02 | 6,409 | $6.14 | 52,214 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Options | Common Shares | Disposition | 2024-12-02 | 10,000 | $2.69 | 10,000 | $2.69 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 184,698 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
Footnotes
- Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023.
- Shares sold to satisfy tax obligation on option exercise.
- Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023.
Billionaire Hedge Funds
